Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) EPS (Weighted Average and Diluted) (2020 - 2025)

Historic EPS (Weighted Average and Diluted) for Traws Pharma (TRAW) over the last 6 years, with Q3 2025 value amounting to -$0.34.

  • Traws Pharma's EPS (Weighted Average and Diluted) rose 7718.12% to -$0.34 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.71, marking a year-over-year increase of 9480.4%. This contributed to the annual value of -$35.21 for FY2024, which is 5602.09% down from last year.
  • Traws Pharma's EPS (Weighted Average and Diluted) amounted to -$0.34 in Q3 2025, which was up 7718.12% from -$0.11 recorded in Q2 2025.
  • Traws Pharma's EPS (Weighted Average and Diluted)'s 5-year high stood at $2.09 during Q1 2025, with a 5-year trough of -$20.52 in Q2 2024.
  • Its 5-year average for EPS (Weighted Average and Diluted) is -$2.81, with a median of -$0.27 in 2022.
  • In the last 5 years, Traws Pharma's EPS (Weighted Average and Diluted) crashed by 1016000.0% in 2024 and then skyrocketed by 13530.41% in 2025.
  • Quarter analysis of 5 years shows Traws Pharma's EPS (Weighted Average and Diluted) stood at -$0.22 in 2021, then dropped by 22.67% to -$0.27 in 2022, then crashed by 1837.94% to -$5.31 in 2023, then tumbled by 159.56% to -$13.79 in 2024, then surged by 97.54% to -$0.34 in 2025.
  • Its last three reported values are -$0.34 in Q3 2025, -$0.11 for Q2 2025, and $2.09 during Q1 2025.